Safely Treating Molluscum, a Common Skin Condition
A common skin infection that some people try to self-diagnose and treat is molluscum contagiosum. But by doing so, you run the risk of delaying the diagnosis and treatment of a potentially serious condition. The FDA has not approved any nonprescription products for the treatment of molluscum. (Source: FDA Consumer Health Information Updates)
Source: FDA Consumer Health Information Updates - August 21, 2023 Category: Consumer Health News Authors: FDA Source Type: news
FDA Approves Topical Treatment for Molluscum Contagiosum
MONDAY, July 24, 2023 -- The U.S. Food and Drug Administration has approved the topical solution Ycanth (cantharidin) for the treatment of molluscum contagiosum (molluscum) in adult and pediatric patients (aged 2 years and older).
Ycanth uses a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 24, 2023 Category: General Medicine Source Type: news
FDA Approves Topical Treatment for Molluscum Contagiosum, Ycanth
MONDAY, July 24, 2023 -- The U.S. Food and Drug Administration has approved the topical solution Ycanth (cantharidin) for the treatment of molluscum contagiosum (molluscum) in adult and pediatric patients (aged 2 years and older).
Ycanth uses a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 24, 2023 Category: General Medicine Source Type: news
First Treatment Approved for Molluscum Contagiosum
(MedPage Today) -- Topical cantharidin (Ycanth) was approved as the first treatment specifically for molluscum contagiosum, the FDA announced.
Molluscum contagiosum is a viral skin infection that affects as many as 6 million Americans, mostly... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - July 24, 2023 Category: Infectious Diseases Source Type: news
FDA Approves Cantharidin for Treating Molluscum Contagiosum FDA Approves Cantharidin for Treating Molluscum Contagiosum
The product is a drug-device combination that contains a formulation of cantharidin solution (0.7%), delivered topically via a single-use applicator.MDedge News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - July 24, 2023 Category: Allergy & Immunology Tags: Dermatology News Source Type: news
FDA Approves Ycanth (cantharidin) Topical Solution for the Treatment of Molluscum Contagiosum
WEST CHESTER, PA–Jul 21, 2023 (GLOBE NEWSWIRE)– Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 21, 2023 Category: Drugs & Pharmacology Source Type: news
Don ’t Use Products Marketed to Treat Molluscum, a Common Skin Condition
A common skin infection that some people try to self-diagnose and treat is molluscum contagiosum. But by doing so, you run the risk of delaying the diagnosis and treatment of a potentially serious condition. The FDA has not approved any products for the treatment of molluscum. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 1, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
At-Home Topical Therapy for Molluscum Contagiosum Gets High Marks
(MedPage Today) -- NEW ORLEANS -- Almost 40% of patients with molluscum contagiosum, some with dozens of lesions, had complete or near-complete clearance after 12 weeks of nitric oxide-releasing gel, the largest-ever randomized trial of the skin... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 23, 2023 Category: Dermatology Source Type: news
FDA Accepts Application for Topical Molluscum Treatment FDA Accepts Application for Topical Molluscum Treatment
If approved, berdazimer gel would be the first FDA-approved prescription product for molluscum contagiosum in the United States.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 8, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Verrica Pharmaceuticals Announces FDA Acceptance of Filing of Resubmitted NDA for VP-102 for the Treatment of Molluscum Contagiosum
WEST CHESTER, PA– February 27, 2023 (GLOBE NEWSWIRE)– Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions,... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - February 27, 2023 Category: Drugs & Pharmacology Source Type: news
Verrica Pharmaceuticals Announces Resubmission of New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
Potential First FDA-approved Therapy for Treatment of Molluscum Contagiosum
Prevalence of Over 6 Million Molluscum Contagiosum Patients in the U.S. Alone
WEST CHESTER, PA– January 24, 2023 (GLOBE NEWSWIRE)– Verrica... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - January 24, 2023 Category: Drugs & Pharmacology Source Type: news
Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
DURHAM, N.C., Jan. 06, 2023— Novan, Inc. (“the Company” or“Novan”) (Nasdaq: NOVN), announced today that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - January 6, 2023 Category: Drugs & Pharmacology Source Type: news
VeraDermics Inc. Secures Licensing of First-in-Class Antiviral...
VDMC-7269 is the lead asset from a poxvirus-targeting antiviral development program and is potentially a best-in-indication antiviral for molluscum contagiosum with a profile suggestive for low-dose...(PRWeb August 23, 2022)Read the full story at https://www.prweb.com/releases/veradermics_inc_secures_licensing_of_first_in_class_antiviral_targeting_the_treatment_of_molluscum_contagiosum_and_other_poxviruses/prweb18854135.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 23, 2022 Category: Pharmaceuticals Source Type: news
Novel Nitric Oxide Gel Clears Kids' Molluscum Contagiosum Lesions
(MedPage Today) -- A novel nitric oxide-releasing gel led to significantly more patients achieving complete clearance of their lesions from molluscum contagiosum infections compared with a vehicle control, and was safe and well tolerated, a phase... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - July 14, 2022 Category: Dermatology Source Type: news
Picture of Molluscum Contagiosum
Title: Picture of Molluscum ContagiosumCategory: ImagesCreated: 10/19/2009 4:23:00 PMLast Editorial Review: 6/23/2022 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - June 23, 2022 Category: Dermatology Source Type: news
